Clinical Report: New Technologies and Best Practices for In-Office YAG
Background
The expansion of laser privileges for optometrists in the United States has led to an increased incorporation of in-office laser procedures, including YAG capsulotomy. Understanding the indications and contraindications for these procedures is crucial for optometrists.
Data Highlights
No numerical data provided in the source material.
Key Findings
- Approximately half of cataract patients may require YAG capsulotomy due to posterior capsule opacification.
- Indications for YAG capsulotomy include symptomatic vision loss, glare, and obscured retinal views.
- Contraindications include cystoid macular edema and ongoing anti-VEGF therapy.
- Initial laser settings should be adjusted based on opacification density, with specific parameters for posterior and anterior capsulotomies.
- Potential complications of YAG capsulotomy include intraocular lens pitting and increased floaters.
- Postoperative follow-up is recommended at 1 week or 1 month, depending on steroid prescription.
Clinical Implications
Optometrists should ensure thorough preoperative planning and patient selection to enhance procedural success in YAG capsulotomy. Awareness of potential complications and appropriate postoperative care is essential for optimizing patient outcomes.
Conclusion
Incorporating YAG procedures into optometric practice requires ongoing education and adaptation to new technologies and best practices to ensure effective patient care.
Related Resources & Content
- Nicholas R. Green, OD, MPH, FAAO, Optometric Management, 2026 -- New Technologies and Best Practices for In-Office YAG
- optometric management — Getting YAG in the Bag: Tips for Success
- Ophthalmology Management — SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
- optometric management — Tips and Tricks for In-Office Laser Peripheral Iridotomy
- Cataract in the Adult Eye Preferred Practice Pattern® - Ophthalmology
- Checking your browser - reCAPTCHA
- YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters: A Randomized Clinical Trial - PMC
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.


